ITeos Therapeutics News

ITeos Therapeutics | 8-K: Current report

Jun 14 04:05

ITeos Therapeutics | 8-K: Current report

May 13 19:04

ITeos Therapeutics | DEFA14A: Others

Apr 25 19:10

ITeos Therapeutics | DEF 14A: Definitive information statements

Apr 25 19:05

ITeos Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 6 20:23

ITeos Therapeutics | 8-K: Current report

Jan 10 13:00

ITeos Therapeutics | 8-K: Current report

Dec 8, 2023 05:11

ITeos Therapeutics | 8-K: Current report

Jun 26, 2023 19:53

ITeos Therapeutics | 8-K: Current report

Jun 20, 2023 19:04

ITeos Therapeutics | S-3: Registration statement for specified transactions by certain issuers

May 10, 2023 19:52

ITeos Therapeutics | DEFA14A: Others

Apr 27, 2023 19:09

ITeos Therapeutics | DEF 14A: Definitive proxy statements

Apr 27, 2023 19:05

ITeos Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 15, 2023 19:13

ITeos Therapeutics | 8-K: Current report

Mar 11, 2023 06:19

ITeos Therapeutics | 8-K: Current report

Feb 4, 2023 05:15

ITeos Therapeutics | 8-K: Current report

Jan 9, 2023 20:01

ITeos Therapeutics | 8-K: Current report

Jun 14, 2022 04:21

ITeos Therapeutics | DEFA14A: Others

Apr 26, 2022 04:19

ITeos Therapeutics | DEF 14A: Definitive proxy statements

Apr 26, 2022 04:03

ITeos Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 24, 2022 04:22